Semi-Annual Consolidated Statement Of Cash Flows

HOGY MEDICAL CO.,LTD. - Filing #7332149

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
4,075,000,000 JPY
3,041,000,000 JPY
5,805,000,000 JPY
6,189,000,000 JPY
Depreciation
6,607,000,000 JPY
3,617,000,000 JPY
Impairment losses
198,000,000 JPY
464,000,000 JPY
Increase (decrease) in allowance for doubtful accounts
0 JPY
0 JPY
Interest and dividend income
-307,000,000 JPY
-156,000,000 JPY
Interest expenses
23,000,000 JPY
29,000,000 JPY
Increase (decrease) in retirement benefit liability
9,000,000 JPY
-107,000,000 JPY
Foreign exchange losses (gains)
42,000,000 JPY
22,000,000 JPY
Loss (gain) on sale of property, plant and equipment
-40,000,000 JPY
JPY
Decrease (increase) in trade receivables
-739,000,000 JPY
-504,000,000 JPY
Decrease (increase) in inventories
-410,000,000 JPY
314,000,000 JPY
Increase (decrease) in trade payables
-40,000,000 JPY
396,000,000 JPY
Other, net
1,007,000,000 JPY
91,000,000 JPY
Subtotal
9,101,000,000 JPY
11,036,000,000 JPY
Interest and dividends received
291,000,000 JPY
127,000,000 JPY
Interest paid
-23,000,000 JPY
-29,000,000 JPY
Income taxes paid
-2,252,000,000 JPY
-1,958,000,000 JPY
Net cash provided by (used in) operating activities
7,117,000,000 JPY
9,176,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,686,000,000 JPY
-1,318,000,000 JPY
Proceeds from sale of property, plant and equipment
43,000,000 JPY
JPY
Purchase of investment securities
-206,000,000 JPY
-525,000,000 JPY
Loan advances
-50,000,000 JPY
0 JPY
Proceeds from collection of loans receivable
0 JPY
0 JPY
Net cash provided by (used in) investing activities
-3,262,000,000 JPY
-1,951,000,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-1,999,000,000 JPY
-1,999,000,000 JPY
Purchase of treasury shares
0 JPY
0 JPY
Dividends paid
-1,892,000,000 JPY
-1,697,000,000 JPY
Net cash provided by (used in) financing activities
-3,892,000,000 JPY
-3,142,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
310,000,000 JPY
448,000,000 JPY
Net increase (decrease) in cash and cash equivalents
272,000,000 JPY
4,531,000,000 JPY
Cash and cash equivalents
18,623,000,000 JPY
18,351,000,000 JPY
13,820,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.